Xponance Inc. Cuts Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Xponance Inc. trimmed its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 6.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 101,536 shares of the pharmacy operator’s stock after selling 7,428 shares during the period. Xponance Inc.’s holdings in Walgreens Boots Alliance were worth $2,651,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in WBA. International Assets Investment Management LLC grew its stake in Walgreens Boots Alliance by 11.3% in the 3rd quarter. International Assets Investment Management LLC now owns 42,662 shares of the pharmacy operator’s stock valued at $897,000 after acquiring an additional 4,331 shares during the last quarter. CWM LLC boosted its stake in shares of Walgreens Boots Alliance by 53.2% during the 3rd quarter. CWM LLC now owns 33,393 shares of the pharmacy operator’s stock worth $743,000 after purchasing an additional 11,602 shares during the last quarter. IFP Advisors Inc boosted its stake in shares of Walgreens Boots Alliance by 15.3% during the 3rd quarter. IFP Advisors Inc now owns 20,975 shares of the pharmacy operator’s stock worth $466,000 after purchasing an additional 2,784 shares during the last quarter. Global Retirement Partners LLC boosted its stake in shares of Walgreens Boots Alliance by 16.3% during the 3rd quarter. Global Retirement Partners LLC now owns 12,890 shares of the pharmacy operator’s stock worth $287,000 after purchasing an additional 1,804 shares during the last quarter. Finally, HB Wealth Management LLC boosted its stake in shares of Walgreens Boots Alliance by 48.5% during the 3rd quarter. HB Wealth Management LLC now owns 11,019 shares of the pharmacy operator’s stock worth $245,000 after purchasing an additional 3,598 shares during the last quarter. 58.59% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CFO Manmohan Mahajan acquired 6,000 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The shares were bought at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, CFO Manmohan Mahajan acquired 6,000 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The shares were bought at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Valerie B. Jarrett acquired 4,456 shares of the company’s stock in a transaction dated Monday, January 29th. The shares were purchased at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the purchase, the director now directly owns 4,456 shares of the company’s stock, valued at $99,992.64. The disclosure for this purchase can be found here. Insiders have bought 13,456 shares of company stock worth $270,423 over the last 90 days. Company insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Trading Down 0.1 %

NASDAQ WBA opened at $18.22 on Tuesday. Walgreens Boots Alliance, Inc. has a one year low of $17.51 and a one year high of $35.54. The company’s 50 day moving average price is $20.33 and its 200 day moving average price is $21.89. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The company had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.16 earnings per share. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

WBA has been the topic of several analyst reports. HSBC reaffirmed a “reduce” rating and set a $20.00 price target (down from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Bank of America decreased their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research note on Tuesday, March 26th. UBS Group decreased their price target on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 3rd. Finally, Morgan Stanley decreased their target price on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a research report on Monday, April 1st. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and an average price target of $24.36.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.